MOH
- Status: likely_approved
🇮🇱 Bystolic in Israel
Bystolic (nebivolol) regulatory status in Israel.
Marketing authorisations
MOH
- Status: likely_approved
MOH
- Status: likely_approved
MOH
- Status: likely_approved
MOH
- Status: likely_approved
Bystolic in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Israel
Frequently asked questions
Is Bystolic approved in Israel?
Yes. MOH has authorised it; MOH has authorised it; MOH has authorised it.
Who is the marketing authorisation holder for Bystolic in Israel?
Allergan is the originator. The local marketing authorisation holder may differ — check the official source linked above.